Colgate-Palmolive Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Colgate-Palmolive heeft een totaal eigen vermogen van $836.0M en een totale schuld van $8.4B, wat de schuld-eigenvermogensverhouding op 1009.1% brengt. De totale activa en totale passiva bedragen respectievelijk $16.8B en $15.9B. De EBIT Colgate-Palmolive is $4.3B waardoor de rentedekking 18.1 is. Het heeft contanten en kortetermijnbeleggingen van $1.5B.
Belangrijke informatie
1,009.1%
Verhouding schuld/eigen vermogen
US$8.44b
Schuld
| Rente dekkingsratio | 18.1x |
| Contant | US$1.49b |
| Aandelen | US$836.00m |
| Totaal verplichtingen | US$15.94b |
| Totaal activa | US$16.77b |
Recente financiële gezondheidsupdates
These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well
Sep 11
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Jun 06Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Oct 02Recent updates
Colgate-Palmolive Company's (NYSE:CL) Intrinsic Value Is Potentially 63% Above Its Share Price
Nov 20If EPS Growth Is Important To You, Colgate-Palmolive (NYSE:CL) Presents An Opportunity
Oct 26Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now
Oct 25Colgate-Palmolive: Very Close To A Buy Following Recent Pullback
Oct 17Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)
Sep 30These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well
Sep 11Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down
Aug 27Colgate-Palmolive: Stability Pillar Reached Its Fair Value
Aug 19An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued
Aug 12Colgate-Palmolive: Good Growth Prospects Ahead
Aug 06Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)
Jul 11Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings
Jul 10Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite
Jun 23Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Jun 06Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital
May 21Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report
Apr 30Colgate-Palmolive: Loading Up Ahead Of Earnings
Apr 16Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E
Apr 02Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?
Feb 14Colgate-Palmolive: I'm Buying Before Interest Rates Decrease
Feb 14Colgate-Palmolive: Brushing Up Profits In Q4 2023
Jan 30Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult
Jan 01Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)
Dec 20Colgate-Palmolive Stock And Its Real Value
Nov 29Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On
Nov 14Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends
Nov 06Colgate-Palmolive: Own This Dividend King At The Right Price
Oct 31Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now
Oct 13Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Oct 02Colgate-Palmolive: Dividend King With Limited Growth
Sep 27An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued
Sep 11Colgate-Palmolive: Improving Prospects And A Reasonable Valuation
Sep 09Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World
Aug 16Colgate And The Importance Of Sales Growth, Expectations Matter
Aug 09Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business
Aug 03Colgate-Palmolive: Challenging Growth Prospects
Jul 10Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48
Jun 27Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48
Jun 13Colgate-Palmolive: The Reasons We Are Becoming More Cautious
Jun 05Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $5.8B ) CL } overtreffen de korte termijn passiva ( $5.6B ).
Langlopende schulden: De kortetermijnactiva van CL ( $5.8B ) dekken de langetermijnschulden ( $10.4B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 830.4% ) CL wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van CL is de afgelopen 5 jaar gedaald van 4684.5% naar 1009.1%.
Schuldendekking: De schuld van CL wordt goed gedekt door de operationele kasstroom ( 47.1% ).
Rentedekking: De rentebetalingen op de schuld van CL worden goed gedekt door EBIT ( 18.1 x dekking).